跨膜和卷轴-卷轴2与人类大脑中阿尔茨海默病的病理学有关
Paul C R Hopkins1, Claire Troakes2, Andrew King2
1Centre for Developmental Neurobiology, King's College London, London, UK.
Brain pathology (Zurich, Switzerland)
|July 31, 2024
概括
跨膜和卷轴2 (TMCC2) 蛋白与粉样蛋白前体蛋白 (APP) 相互作用,与阿尔茨海默病 (AD) 病理学有关,特别是密集的核心斑块和唐氏综合征AD的改变.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 跨膜和卷轴卷轴2 (TMCC2) 是同类的Drosophila dementin,与神经退行相关.
- TMCC2和dementin与粉样蛋白前体蛋白 (APP) 相互作用,这是阿尔茨海默病 (AD) 的关键因素.
研究的目的:
- 研究人类TMCC2在神经退行机制中的作用,特别是在阿尔茨海默病中.
- 在人类大脑样本中检查TMCC2表达及其与AD病理学的关联.
主要方法:
- 双重免疫细胞化学评估TMCC2和APP在人类皮层的同定位.
- 在晚期发病的AD,家族性AD (APP Val717突变) 和唐氏综合征AD大脑中分析TMCC2表达.
- 西方斑点分析用于识别人脑提取物中的TMCC2蛋白异型.
主要成果:
- TMCC2和APP在对照人体皮质中显示了类似的分布.
- 在晚期发病的AD中,TMCC2免疫活性局部化到密集的核心老年斑块和神经元缩,而不是扩散斑块或病.
- 唐氏综合征AD表现出明显的TMCC2免疫反应特征,表明病理变化的增强.
- 人类大脑TMCC2存在多种异型,其丰度因大脑区域而异,受APOE基因型和痴呆状态的影响.
结论:
- 人类TMCC2通过与APP的相互作用和与密集的核心斑块的关联,与AD病变发生有关.
- 在唐氏综合征AD中,TMCC2表现出改变的表达和病理,表明它在这种疾病中发挥了特定的作用.
- TMCC2蛋白异型及其调节受到人类大脑中的遗传因素 (APOE) 和疾病状态的影响.
更多相关视频
09:35Enrichment of Detergent-insoluble Protein Aggregates from Human Postmortem Brain
Published on: October 24, 2017
12.1K
10:51Consensus Brain-derived Protein, Extraction Protocol for the Study of Human and Murine Brain Proteome Using Both 2D-DIGE and Mini 2DE Immunoblotting
Published on: April 10, 2014
16.1K
相关概念视频
Alzheimer's Disease: Overview
456
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
456
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K
